Entero Therapeutics logo

Entero Therapeutics Share Price Today

(NASDAQ: ENTO)

Entero Therapeutics share price is $0.56 & ₹48.70 as on 6 Mar 2025, 2.30 'hrs' IST

$0.56

0.06

(10.98%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Entero Therapeutics share price in Dollar and Rupees. Guide to invest in Entero Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Entero Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Entero Therapeutics share price movements

  • Today's Low: $0.50
    Today's High: $0.58

    Day's Volatility :13.24%

  • 52 Weeks Low: $0.19
    52 Weeks High: $3.16

    52 Weeks Volatility :94.15%

Entero Therapeutics (ENTO) Returns

PeriodEntero Therapeutics IncIndex (Russel 2000)
3 Months
-23.59%
0.0%
6 Months
25.87%
0.0%
1 Year
-82.92%
0.0%
3 Years
-82.92%
-11.6%

Entero Therapeutics (ENTO) Key Statistics

in dollars & INR

Previous Close
$0.5089
Open
$0.479
Today's High
$0.5756
Today's Low
$0.499399
Market Capitalization
$1.1M
Today's Volume
$28.0K
52 Week High
$3.16
52 Week Low
$0.185
Revenue TTM
$0.0
EBITDA
$-20.9M
Earnings Per Share (EPS)
$-11.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-15.28%

How to invest in Entero Therapeutics Stock (ENTO) from India?

It is very easy for Indian residents to invest directly in Entero Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Entero Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Entero Therapeutics or ENTO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Entero Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Entero Therapeutics shares which would translate to 1.553 fractional shares of Entero Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Entero Therapeutics, in just a few clicks!

Returns in Entero Therapeutics (ENTO) for Indian investors in Rupees

The Entero Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Entero Therapeutics investment value today

Current value as on today

₹23,755

Returns

₹76,245

(-76.25%)

Returns from Entero Therapeutics Stock

₹81,208 (-81.21%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Entero Therapeutics (ENTO)

86%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Entero Therapeutics Stock from India on INDmoney has increased by 86% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Entero Therapeutics

Analyst Forecast on Entero Therapeutics Stock (ENTO)

What analysts predicted

Upside of 6328.57%

Target:

$36.00

Current:

$0.56

Insights on Entero Therapeutics Stock (Ticker Symbol: ENTO)

  • Price Movement

    In the last 7 days, ENTO stock has moved up by 7.1%

Entero Therapeutics Technicals Summary

Sell

Neutral

Buy

Entero Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Entero Therapeutics (ENTO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Entero Therapeutics Inc logo
-10.72%
25.87%
-82.92%
-82.92%
-82.92%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Entero Therapeutics Inc logo
NA
NA
NA
-1.13
-0.15
-0.27
NA
7.99
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Entero Therapeutics Inc logo
NA
$1.1M
-82.92%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Entero Therapeutics

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company's pipeline candidates include latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides, currently under Phase 2 studies; and capeserod, a selective 5-HT4 receptor partial agonist under Phase 1 studies for the treatment of gastroparesis. It is also involved in the development of adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, currently under Phase 2 studies for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis; and niclosamide, an oral small molecule with anti-inflammatory inhibitor therapy, currently under Phase 2 studies for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, as well as immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is based in Boca Raton, Florida.
Organization
Entero Therapeutics
Employees
9
CEO
Mr. Richard Joel Paolone
Industry
Miscellaneous

Management People of Entero Therapeutics

NameTitle
Ms. Sarah Romano CPA
Chief Financial Officer
Mr. Richard Joel Paolone
Interim CEO & Director

Important FAQs about investing in ENTO Stock from India :

What is Entero Therapeutics share price today?

Entero Therapeutics share price today stands at $0.56, Open: $0.48 ; Previous Close: $0.51 ; High: $0.58 ; Low: $0.50 ; 52 Week High: $3.16 ; 52 Week Low: $0.19.

The stock opens at $0.48, after a previous close of $0.51. The stock reached a daily high of $0.58 and a low of $0.50, with a 52-week high of $3.16 and a 52-week low of $0.19.

Can Indians buy Entero Therapeutics shares?

Yes, Indians can invest in the Entero Therapeutics (ENTO) from India.

With INDmoney, you can buy Entero Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Entero Therapeutics at zero transaction cost.

How can I buy Entero Therapeutics shares from India?

It is very easy to buy Entero Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Entero Therapeutics (ENTO) be purchased?

Yes, you can buy fractional shares of Entero Therapeutics with INDmoney app.

What are the documents required to start investing in Entero Therapeutics stocks?

To start investing in Entero Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Entero Therapeutics Stock (ENTO)?

Today’s highest price of Entero Therapeutics (ENTO) is $0.58.

Today’s lowest price of Entero Therapeutics (ENTO) is $0.50.

What is today's market capitalisation of Entero Therapeutics?

Today's market capitalisation of Entero Therapeutics ENTO is 1.1M

What is the 52 Week High and Low Range of Entero Therapeutics Stock (ENTO)?

  • 52 Week High

    $3.16

  • 52 Week Low

    $0.19

What are the historical returns of Entero Therapeutics (ENTO)?

  • 1 Month Returns

    -10.72%

  • 3 Months Returns

    25.87%

  • 1 Year Returns

    -82.92%

  • 5 Years Returns

    -82.92%

Who is the Chief Executive Officer (CEO) of Entero Therapeutics ?

Mr. Richard Joel Paolone is the current Chief Executive Officer (CEO) of Entero Therapeutics.